Got Peripheral Artery Disease?
Patients with atherosclerotic peripheral arterial disease (PAD) saw improved results from revascularization to treat intermittent claudication (IC), a common symptom of PAD, a new study found.
New VTE Guidelines Released
The American College of Chest Physicians (CHEST) issued some new guidelines for the treatment of venous thromboembolism (VTE).
Novel Blood Clot Rx Shows Potential
Antiplatelet medications, while highly effective, can put surgical patients at risk of serious bleeding. But a new, safer drug may be on the horizon.
What Women Need to Know About Blood Clots
Taking "the pill" has become a routine part of life for many women around the world. But that doesn't mean birth control pills are entirely without risk.
FDA Approves Rx for Bone Marrow Disease
The U.S. Food and Drug Administration today approved a new use for Jakafi (ruxolitinib) to treat patients with polycythemia vera, a chronic type of bone marrow disease. Jakafi is the first drug approved by the FDA for this condition.
Rare Diseases You've Never Heard Of
In an effort to help raise awareness about rare diseases, here is an introduction to several rare conditions you might not know existed.
Celebrities Affected by Multiple Myeloma
Multiple myeloma is a blood cancer that affects the body’s plasma cells, a type of blood cell that is responsible for making antibodies that help protect from sickness. Here’s a list of celebrities who’ve been affected by this form of cancer.
When Babies Don't Get Vitamin K
The more that has been learned about the first few days of a baby's life, the more doctors understand about how to keep newborns healthy. But parents are partners in treatment too.
Raising Awareness of Sickle Cell
Sickle cell disease is a public health concern in the US and worldwide. There is no easy cure, but patients can live normal and productive lives with prompt detection and the right treatment.
FDA Clears First Blood Tracking Device That Uses Radio Frequency Identification Technology
iTrace for Blood Centers, the first application to use Radio Frequency Identification (RFID) technology in blood establishments to assist in enhancing blood safety by preventing the release of unsuitable blood components, was cleared today by the US Food and Drug Administration.